© 2023 MJH Life Sciences and Patient Care Online. All rights reserved.
© 2023 MJH Life Sciences™ and Patient Care Online. All rights reserved.
""DOURRON OB/GYN ASSOCIATES, P.C.""
2675 N DECATUR RD STE 301
June 30, 2016
The good news is that a few diabetes drugs now show valid cardioprotective benefits; the bad news is the drugs are unaffordable for many.
June 02, 2016
The new evidence-based, comprehensive recommendations replace 2012's "piecemeal" effort to guide clinical management.
March 10, 2016
The annual visit rate to a physician for obesity in 2012 was 49 per 1000 people, according to the latest CDC report.
February 18, 2016
Surveys show that up to 48% of Americans are actively trying to lose weight. New research finds reliable support in short supply.
January 13, 2016
British modelling study calculates significant drops in overweight, obesity, and obesity-related diabetes via reducing sugar in beverages alone.
September 30, 2015
The empagliflozin CV benefit was "astounding" and a first for any diabetes drug, but what does it actually mean?
July 25, 2015
New study findings are grim, suggesting that fewer than 1% of the obese who work at weight loss will have sustained success.
June 25, 2015
A large review ties nut consumption to a lower incidence of cancer, but not diabetes.
April 20, 2015
Underweight means highest risk, say researchers.
March 11, 2015
The FDA will require labels on prescription testosterone products that disclose a possible increased risk of heart attacks and strokes. A “black box” warning won’t be added.